Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Vosaroxin – Treatment for Myeloid Leukaemia

Vosaroxin is a first-in-class anticancer quinolone derivative indicated for the treatment of acute myeloid leukaemia. It is being developed by Sunesis Pharmaceuticals.



Close
Close
Close

Go Top